EXOZ
eXoZymes, Inc.
6.20$
-1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +1.1% | -1.9% | +4.3% | +2.5% | -0.9% | -399.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -134.6% | – | – | |
| – | -44.9% | -76.0% | +269.2% | +1,870.0% | -49.6% | -14.5% | +204.8% | -12.9% | -8.8% | +39.6% | +51.5% | -8.6% | +0.8% | +28.3% | – | |
| – | -0.8% | -32.2% | +99.8% | +38.7% | +44.8% | +49.3% | -18.6% | +204.7% | -49.2% | +23.8% | -23.8% | +22.0% | -24.7% | +27.2% | – | |
| – | -26.5% | -26.2% | +120.0% | +151.4% | +2.4% | +25.0% | +22.4% | +24.2% | -1.9% | +31.7% | -1.0% | +18.7% | -20.5% | +27.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +49.9% | -26.2% | – | – | -22.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.